BNP und NT-proBNP nach EBM abrechnen

被引:0
|
作者
Springer Medizin
机构
关键词
D O I
10.1007/s15006-018-0968-0
中图分类号
学科分类号
摘要
[No abstract available]
引用
收藏
页码:26 / 26
相关论文
共 50 条
  • [21] Evaluating the evidence for assessing BNP and NT-proBNP levels
    Busse, J. W.
    Bassler, D.
    Guyatt, G. H.
    CLINICAL BIOCHEMISTRY, 2008, 41 (4-5) : 227 - 230
  • [22] Renal handling of BNP and NT-proBNP in hypertensive subjects
    van Kimmenade, RR
    Bakker, JA
    Houben, AJ
    Kroon, AA
    Rennenberg, R
    Crijns, HJ
    van Dieijen-Visser, MP
    de Leeuw, PW
    Pinto, YM
    CIRCULATION, 2005, 112 (17) : U663 - U663
  • [23] BNP and NT-proBNP Interpretation in the Neprilysin Inhibitor Era
    Marco Sbolli
    Christopher deFilippi
    Current Cardiology Reports, 2020, 22
  • [25] BNP and NT-proBNP in patients with renal failure and haemodialysis
    Baum, H
    von Meyer, A
    Heemann, U
    Hallbach, J
    CLINICA CHIMICA ACTA, 2005, 355 : S112 - S113
  • [26] Clinical utility of the cardiac markers BNP and NT-proBNP
    Buchner, S
    Riegger, G
    Luchner, A
    ACTA MEDICA AUSTRIACA, 2004, 31 (04) : 144 - 151
  • [27] The Effect of Renal Dysfunction on BNP, NT-proBNP, and Their Ratio
    Srisawasdi, Pornpen
    Vanavanan, Somlak
    Charoenpanichkit, Charaslak
    Kroll, Martin H.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 133 (01) : 14 - 23
  • [28] Comparison between BNP and NT-proBNP in pediatric populations
    Tawiah, Kwaku D.
    Franks, Caroline E.
    Tang, Jessica
    Gazit, Avihu
    Dietzen, Dennis J.
    Farnsworth, Christopher W.
    CLINICAL BIOCHEMISTRY, 2022, 109 : 74 - 78
  • [29] Renal Dysfunction, Hemodialysis, and the NT-proBNP/BNP Ratio
    Jacobs, Leo H.
    Mingels, Alma M.
    Wodzig, Will K.
    van Dieijen-Visser, Maria P.
    Kooman, Jeroen P.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 134 (03) : 516 - 517
  • [30] Plasma concentrations of BNP and NT-proBNP in patients on hemodialysis
    Wahl, H
    Graf, S
    Ashayer, S
    Scheckel, B
    Fassbinder, W
    Renz, H
    CLINICAL CHEMISTRY, 2004, 50 (06) : A20 - A21